Institut Pierre Richet IPR) Institut National de Sante Publique

Facility Details

Region
West Africa

GLP Lead
IVCC

GLP Compliance Progress

Status 1. Site Development

GLP Compliance Target 2020 Q3

Product Testing

IRS

  • Lab Trials (Phase I)
  • Small Scale Trials (Phase II)
  • Large Scale Trials (Phase III)

LLINS

  • Lab Trials (Phase I)
  • Small Scale Trials (Phase II)
  • Large Scale Trials (Phase III)

SPACE SPRAYS

  • Lab Trials (Phase I)
  • Small Scale Trials (Phase II)
  • Large Scale Trials (Phase III)

LARVICIDES

  • Lab Trials (Phase I)
  • Small Scale Trials (Phase II)
  • Large Scale Trials (Phase III)

TOPICAL REPELLENTS

  • Lab Trials (Phase I)
  • Small Scale Trials (Phase II)
  • Large Scale Trials (Phase III)

GENETICALLY MODIFIED MOSQUITOES

  • Lab Trials (Phase I)
  • Small Scale Trials (Phase II)
  • Large Scale Trials (Phase III)

Laboratory Strains
- Strain Names & Species

An. gambiae Kisumu (SS);
Cx. S-lab (SS);
VKPER (RR).

Wild Populations (and Resistance Profiles) - Species

An. gambiae Mbé.


Hut testing possible in the following months of the year

  • march
  • april
  • may
  • june
  • july
  • august
  • september
  • october
  • november

Village Scale Trials possible in the following months of the year

  • ht-march
  • ht-april
  • ht-may
  • ht-june
  • ht-july
  • ht-august
  • ht-september
  • ht-october
  • ht-november

Contact Details

Contact
Alphonsine Koffi / Raphael N'Guessan

Phone Number
00(225) 07 62 08 86 / 00 (225)79 40 40 01

Email Address
koffi_alphonsine@yahoo.fr
raphael.n'guessan@lshtm.ac.uk

Website